Skip to content

3D gaze stability as a meausure for visual-vestibular function

3D gaze stability as a meausure for visual-vestibular function - Gaze stability in 3D

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56520
Enrollment
100
Registered
2024-02-12
Start date
2023-09-01
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebellopontine angle tumor vestibular schwannoma

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Normal hearing in the unaffected ear - Fuctional vision in both eyes - Informed concent (toestemmingsformulier). - Solitary vestibular schwannoma - Stationairy retinal dysfunction syndrom

Exclusion criteria

Exclusion criteria: - neurological or psychiatric disease - dizziness due to side effect medication - Alcohol or drug abuse up to 6 months previously - HIV - Hepatitis B - History of *closed head injury*, - Pregnancy

Design outcomes

Primary

MeasureTime frame
Primary: • Retinal slip velocity in °/s, the movement of the eye relative to the image.

Secondary

MeasureTime frame
Secondary: • Saccade and smooth pursuit amplitude and latency as a reference for the accuracy of oculomotor response when viewing a moving image with a stationary head. • Hearing threshold in dB as a reference for the integrity of the audiovestibular end organ. • Speech discrimination in % as a reference for the integrity of the audiovestibular end organ. • Visual acuity in % as a reference for the integrity of the input from the visual system. • DHI score, ERGO score, and VAS score for documentation of the experience of balance complaints.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)